PubMed 26188173
Referenced in: none
Automatically associated channels: Kv7.1
Title: Engineering a peptide inhibitor towards the KCNQ1/KCNE1 potassium channel (IKs).
Authors: Youtian Hu, Jing Chen, Bin Wang, Weishan Yang, Chuangeng Zhang, Jun Hu, Zili Xie, Zhijian Cao, Wenxin Li, Yingliang Wu, Zongyun Chen
Journal, date & volume: Peptides, 2015 Sep , 71, 77-83
PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/26188173
Abstract
The KCNQ1/KCNE1 channel (IKs) plays important roles in the physiological and pathological process of heart, but no potent peptide acting on this channel has been reported. In this work, we found that the natural scorpion venom hardly inhibited KCNQ1/KCNE1 channel currents. Based on this observation, we attempted to use three natural scorpion toxins ChTX, BmKTX and OmTx2 with two different structural folds as templates to engineer potent peptide inhibitors towards the KCNQ1/KCNE1 channel. Pharmacological experiments showed that when we screen with 1μM MT2 peptide, an analog derived from BmKTX toxin, KCNQ1/KCNE1 channel currents could be effectively inhibited. Concentration-dependent experiments showed that MT2 inhibited the KCNQ1/KCNE1 channel with an IC50 value of 4.6±1.9μM. The mutagenesis experiments indicated that MT2 peptide likely used Lys26 residue to interact with the KCNQ1/KCNE1 channel. With MT2 as a new template, we further designed a more potent MT2-2 peptide, which selectively inhibited the KCNQ1/KCNE1 channel with an IC50 of 1.51±0.62μM. Together, this work provided a much potent KCNQ1/KCNE1 channel peptide inhibitor so far, and highlighted the role of molecular strategy in developing potent peptide inhibitors for the natural toxin-insensitive orphan receptors.